| .
Contents . . . . . . . .
|
Arachnoiditis: by L.O. Simpson & M.G. Anderson REFERENCES: 1 Simpson L.O., Murdoch J.C., Herbison G.P. Red cell shape changes following trigger finger fatigue in subjects with chronic tiredness and healthy controls. N.Z. Med.J. 1993. 106: 104-7 2 Simpson. L.O. Red cell shape in health and disease. In: Physiological Fluid Dynamics III. Swamy N.V.C. and Megha Singh (eds). Varosa Publishing House. New Delhi. 1991. 3 Simpson L.O. Blood from healthy animals and humans contain non-discocytic erythrocytes. Br J Haematol 1989; 73: 561-564 4 Simpson L.O. Chronic tiredness and idiopathic chronic fatigue – a connection? New Jersey Medicine 1992; 89: 211-216 5 Kury P.G., Ramwell P.W., McConnell H.M. The effect of Prostaglandin E-1 and E-2 on the human erythrocyte as monitored by spin labels. Biochim Biophys Res Commun 1974; 56: 478-483 6 Rasmussen H, Lake W, Allen J.C. The effect of catecholamines and prostaglandins upon human and rat erythrocytes. Biochim Biophys Acta 1975; 411: 63-73 7 Simpson L.O. Altered blood rheology in the pathogenesis of Diabetes and other neuropathies. Muscle and Nerve. 1988. 11: 725-744 8 Simpson L.O. The results from red cell shape analyses of blood samples from members of myalgic encephalomyelitis organisations in 4 countries. Journal of Orthomolecular Medicine 1997; 12: 221-226. 9 Smith S., Patron Arachnoiditis Trust, UK. Arachnoiditis – Global Survey, 1999. Unpublished article. 10 Long D.M. Chronic Adhesive Spinal Arachnoidits: Pathogenesis, Prognosis, and Treatment. Neurosurgery Quarterly 1992. 2(4): 296-319 11 Tomlinson D.R., Robinson J.P., Compton A.M., Keen P. Essential Fatty Acid Treatment – effects on nerve conduction, polyol pathway and axonal transport in streptozotocin diabetic rats. Diabetologia. 1989 32 : 655-699 12 Stevens E.J., Lockett M.J., Carrington A.L., Tomlinson D.R. Essential Fatty Acid treatment prevents nerve ischaemia and associated conduction anomalies in rats with experimental diabetes mellitus. Diabetologia. 1993 36 : 397-401 13 Burton C. http://www.ilbnc.com. 1998: Adhesive Arachnoiditis – Etiology. 14 Smith S. Patron, Arachnoiditis Trust U.K. Spinal Stenosis. Unpublished article. 15 Simpson L.O. Personal communication. 16 Murukami et al., Effects of intravenous lipoprostaglandin E-1 on neurogenic intermittent claudication. J. Spinal Disord. 1997. (Quoted by Smith.) 17 Martin M.F.R., Tooke J.E. Effects of Prostaglandin E-1 on microvascular haemodynamics in progressive systemic sclerosis. Br J Med 1982; 285: 1688-1690. 18 Pardy B.J., Hoane M.C. et al. Prostaglandin E-1 in severe Raynaud’s phenomenon. Surgery 1982; 92: 953-965. 19 Kyle V., Hazelman B. Prostaglandin E-1 and peripheral vascular disease. Lancet 1983; 2: 282. 20 Manku M.S., Horrobin D.F., Morse N., Kyle V., Jenkins K. Reduced levels of prostaglandin precursors in the blood of atopic patients: defective delta-6-desaturase function as a biochemical basis. Prost Leuko Med 1982:9:615-628. 21 Birrer, Cynthia. The Medical Cop-Out. Pub. Human and Rousseau, S.A. 1976. |